FDA clears Smith & Nephew wound system; Scott Solano joins Veniti as COO;

> Smith & Nephew ($SNN) has received FDA clearance of the pocket-sized PICO system, a single-use, negative-pressure wound therapy system. Smith & Nephew statement

> St. Louis startup Veniti has added Scott Solano to its executive team as COO. Previously, Solano was senior VP and chief technology officer at AngioDynamics, where he also served as interim CEO in 2011. Veniti release

> NxStage Medical's ($NXTM) Medisystems in-center business and B. Braun Medical have agreed to extend a supply agreement through which Medisystems will supply B. Braun with its Streamline blood tubing sets for use on certain products. NxStage release

> Zeltiq Aesthetics ($ZLTQ) has announced the retirement of CFO John Howe. Joshua Brumm has been named VP and CFO. Zeltiq release

> VisionGate has achieved full automation of its Cell-CTsystem, a proprietary imaging platform that generates high-resolution 3-D biosignatures from intact cells. Development was funded in part by a $2.6 million grant from the National Institutes of Health's BRDG-SPAN program. VisionGate release

And Finally... With hip joints and breast implants in Europe, a manufacturer is not required to win a license based on evidence of safety and efficacy from clinical trials, but only get the CE Mark—the same mark a Chinese toy company, for example, would have to obtain to sell yo-yos. News

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.